LynxCare is excited to announce the appointment of Laurent van Lerberghe, former Chief Strategy Officer at Sanofi, as Investor and Board Advisor. LynxCare is a scale-up company in Clinical Artificial Intelligence part of the CB Insights Global Digital Health 150, supported by renowned VC investors MTIP (CH), Elaia (FR), B2Ventures (CH-DE) and Heran partners (BE).
Read the blog articleThrough our comprehensive datasets, including an estimated 23.500 patients and 235 variables, you can gain further insights into the complexities of heart failure.
Read the blog articleLeveraging cutting-edge AI and disease-specific Clinical NLP, LynxCare unlocks the richness of hospital data (incl. narrative text in medical records - unstructured data), building harmonized databases. Hospitals and life sciences can in turn extract clinical insights from fresh Real-World Data for research and improving patient care.
Read the blog articleUnlocking New Possibilities for Pharma with our Lung Cancer datasets.
Read the blog articleOur granular and quality-controlled real-world dataset allows in-depth analysis and research into the CLL patient journey.
Read the blog article67% stage I-II breast cancer patients, 14% stage III-IV breast cancer patients - discover more LynxCare datasets insights.
Read the blog articleGain fresh insights into the relationship of specific comorbidities, adverse events and biomarkers with immuno-oncology prognosis through LynxCare's European data asset.
Read the blog articleWe are proud to share that we have successfully renewed our ISO 27001 and NEN 7510 certifications. These certifications are not just badges, but a reflection of our commitment to maintaining the highest information security standards in healthcare!
Read the blog articleLynxCare's comprehensive datasets within its European hospital network offer fresh insights into Immuno-Oncology, Breast Cancer, Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Multiple Myeloma (MM), including comorbidity factors, treatment patterns, and staging.
Read the blog articleWe have a team of MDs, data scientists and software engineers ready to let data drive your outcomes.